(+)-pilocarpine decreases expression EXP 6480464 Pilocarpine results in decreased expression of TNFSF10 mRNA CTD PMID:17971868 (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TNFSF10 mRNA] CTD PMID:31150632 (-)-demecolcine increases expression ISO RGD:1344832 6480464 Demecolcine results in increased expression of TNFSF10 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:1344832 6480464 epigallocatechin gallate results in decreased expression of TNFSF10 mRNA CTD PMID:16084531 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1344832 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TNFSF10 mRNA CTD PMID:22079256 (-)-matairesinol multiple interactions ISO RGD:1344832 6480464 [matairesinol co-treated with TNFSF10 protein modified form] results in increased activity of CASP3 protein, [matairesinol co-treated with TNFSF10 protein modified form] results in increased cleavage of BID CTD PMID:19935713 (R)-lipoic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in decreased expression of TNFSF10 mRNA CTD PMID:23830814 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o, p'-DDT results in increased expression of TNFSF10 mRNA CTD PMID:22937105 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression EXP 6480464 o, p'-DDT analog results in decreased expression of TNFSF10 mRNA CTD PMID:22937105 1,1-dichloroethene decreases expression ISO RGD:732827 6480464 vinylidene chloride results in decreased expression of TNFSF10 mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO RGD:732827 6480464 1, 2-Dimethylhydrazine results in decreased expression of TNFSF10 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate multiple interactions ISO RGD:1344832 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of TNFSF10 mRNA CTD PMID:27344345 17beta-estradiol multiple interactions ISO RGD:1344832 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of TNFSF10 mRNA, [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TNFSF10 mRNA CTD PMID:19619570 , PMID:20660070 17beta-estradiol decreases expression ISO RGD:1344832 6480464 Estradiol results in decreased expression of TNFSF10 mRNA CTD PMID:20106945 more ... 17beta-estradiol increases expression ISO RGD:1344832 6480464 Estradiol results in increased expression of TNFSF10 mRNA CTD PMID:19619570 , PMID:21185374 2,2',4,4',5,5'-hexachlorobiphenyl affects expression ISO RGD:1344832 6480464 2 more ... CTD PMID:20638727 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1344832 6480464 2 more ... CTD PMID:27589474 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1344832 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TNFSF10 mRNA, Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of TNFSF10 mRNA] CTD PMID:11007951 , PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of TNFSF10 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732827 6480464 Tetrachlorodibenzodioxin results in increased expression of TNFSF10 mRNA CTD PMID:12167310 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1344832 6480464 Tetrachlorodibenzodioxin affects the expression of TNFSF10 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1344832 6480464 Tetrachlorodibenzodioxin results in decreased expression of TNFSF10 mRNA CTD PMID:11007951 , PMID:11489354 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of TNFSF10 mRNA CTD PMID:19520675 , PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1344832 6480464 Tetrachlorodibenzodioxin results in increased expression of TNFSF10 mRNA CTD PMID:19619570 2,3-dimethoxynaphthalene-1,4-dione decreases expression ISO RGD:1344832 6480464 2 more ... CTD PMID:17547211 2,4,6-trinitrotoluene affects expression EXP 6480464 Trinitrotoluene affects the expression of TNFSF10 mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:1344832 6480464 Lactic Acid results in decreased expression of TNFSF10 mRNA CTD PMID:30851411 2-trans,6-trans,10-trans-geranylgeranyl diphosphate multiple interactions ISO RGD:1344832 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]], geranylgeranyl pyrophosphate inhibits the reaction [TNFSF10 protein promotes the reaction [Simvastatin results in increased cleavage of PARP1 protein]] CTD PMID:21910007 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:34256052 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1344832 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TNFSF10 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression ISO RGD:732827 6480464 4, 4'-diaminodiphenylmethane results in increased expression of TNFSF10 mRNA CTD PMID:18648102 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of TNFSF10 mRNA CTD PMID:30723492 4,5,6,7-TETRABROMOBENZOTRIAZOLE multiple interactions ISO RGD:1344832 6480464 [4 more ... CTD PMID:16489027 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid increases activity ISO RGD:1344832 6480464 Am 580 results in increased activity of TNFSF10 protein CTD PMID:15703382 4-hydroxyphenyl retinamide decreases expression ISO RGD:732827 6480464 Fenretinide results in decreased expression of TNFSF10 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide multiple interactions ISO RGD:1344832 6480464 [Fenretinide co-treated with TNFSF10 protein] results in increased activity of CASP10 protein more ... CTD PMID:17273769 5-aza-2'-deoxycytidine increases expression ISO RGD:1344832 6480464 Decitabine results in increased expression of TNFSF10 mRNA, Decitabine results in increased expression of TNFSF10 protein CTD PMID:17283156 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1344832 6480464 [[[Decitabine co-treated with IFNG protein] results in increased expression of CASP8 protein] which co-treated with TNFSF10 protein] results in increased activity of CASP8 protein more ... CTD PMID:16607283 more ... 5-azacytidine increases response to substance ISO RGD:1344832 6480464 Azacitidine results in increased susceptibility to TNFSF10 protein CTD PMID:18829727 5-azacytidine increases response to substance ISO RGD:732827 6480464 Azacitidine results in increased susceptibility to TNFSF10 protein CTD PMID:18829727 5-fluorouracil multiple interactions ISO RGD:1344832 6480464 [Fluorouracil co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein more ... CTD PMID:15120327 more ... 5-fluorouracil affects expression ISO RGD:1344832 6480464 Fluorouracil affects the expression of TNFSF10 mRNA CTD PMID:34151400 5-fluorouracil increases expression ISO RGD:732827 6480464 Fluorouracil results in increased expression of TNFSF10 protein CTD PMID:19106633 5-fluorouracil increases activity ISO RGD:1344832 6480464 Fluorouracil results in increased activity of TNFSF10 protein CTD PMID:16373718 5-fluorouracil increases response to substance ISO RGD:1344832 6480464 Fluorouracil results in increased susceptibility to TNFSF10 protein CTD PMID:20876774 5-fluorouracil increases abundance ISO RGD:1344832 6480464 TNFSF10 results in increased abundance of Fluorouracil CTD PMID:11750847 5-fluorouracil increases expression ISO RGD:1344832 6480464 Fluorouracil results in increased expression of TNFSF10 mRNA, Fluorouracil results in increased expression of TNFSF10 protein CTD PMID:19106633 8'-apo-beta,psi-caroten-8'-al increases expression ISO RGD:1344832 6480464 apocarotenal results in increased expression of TNFSF10 mRNA CTD PMID:17034753 9-cis-retinoic acid increases expression ISO RGD:1344832 6480464 Alitretinoin results in increased expression of TNFSF10 mRNA, Alitretinoin results in increased expression of TNFSF10 protein CTD PMID:16449964 [6]-Shogaol multiple interactions ISO RGD:1344832 6480464 [shogaol co-treated with TNFSF10 protein] results in increased cleavage of CASP3 protein more ... CTD PMID:25619640 [6]-Shogaol increases response to substance ISO RGD:1344832 6480464 shogaol results in increased susceptibility to TNFSF10 protein CTD PMID:25619640 acetamide increases expression EXP 6480464 acetamide results in increased expression of TNFSF10 mRNA CTD PMID:31881176 acetylsalicylic acid multiple interactions ISO RGD:1344832 6480464 [Aspirin co-treated with TNFSF10 protein] results in decreased expression of BIRC5 protein more ... CTD PMID:16199534 more ... acetylsalicylic acid multiple interactions EXP 6480464 Aspirin inhibits the reaction [Azoxymethane results in increased expression of TNFSF10 mRNA] CTD PMID:20043115 acetylsalicylic acid increases response to substance ISO RGD:1344832 6480464 Aspirin results in increased susceptibility to TNFSF10 protein CTD PMID:18483385 , PMID:21171083 actinomycin D multiple interactions ISO RGD:1344832 6480464 [Dactinomycin co-treated with TNFSF10 protein] results in increased activity of CASP7 protein more ... CTD PMID:17707539 adenosine multiple interactions ISO RGD:732827 6480464 [Adenosine co-treated with Coformycin] results in decreased expression of TNFSF10 mRNA CTD PMID:11992407 aflatoxin B1 decreases expression ISO RGD:1344832 6480464 Aflatoxin B1 results in decreased expression of TNFSF10 mRNA CTD PMID:27153756 aldehydo-D-glucose decreases expression ISO RGD:1344832 6480464 Glucose results in decreased expression of TNFSF10 mRNA CTD PMID:31655124 all-trans-retinoic acid multiple interactions ISO RGD:1344832 6480464 CYP26A1 protein inhibits the reaction [Tretinoin results in increased activity of TNFSF10 protein] more ... CTD PMID:15703382 more ... all-trans-retinoic acid increases activity ISO RGD:1344832 6480464 Tretinoin results in increased activity of TNFSF10 protein CTD PMID:15703382 all-trans-retinoic acid increases expression ISO RGD:1344832 6480464 Tretinoin results in increased expression of TNFSF10 mRNA, Tretinoin results in increased expression of TNFSF10 protein CTD PMID:11385504 more ... aluminium oxide increases expression ISO RGD:1344832 6480464 Aluminum Oxide analog results in increased expression of TNFSF10 mRNA CTD PMID:23132795 alvocidib increases response to substance ISO RGD:1344832 6480464 alvocidib results in increased susceptibility to TNFSF10 CTD PMID:16951203 alvocidib increases expression ISO RGD:1344832 6480464 alvocidib results in increased expression of TNFSF10 CTD PMID:16820931 alvocidib multiple interactions ISO RGD:1344832 6480464 [alvocidib co-treated with TNFSF10 protein] results in decreased expression of BID protein more ... CTD PMID:16951203 amiloride multiple interactions ISO RGD:1344832 6480464 Amiloride promotes the reaction [TNFSF10 protein affects the localization of CYCS protein] more ... CTD PMID:15607733 , PMID:16059913 amiodarone increases response to substance ISO RGD:1344832 6480464 Amiodarone results in increased susceptibility to TNFSF10 protein CTD PMID:21292685 amiodarone multiple interactions ISO RGD:1344832 6480464 [TNFSF10 co-treated with Amiodarone] results in increased cleavage of BID protein more ... CTD PMID:21292685 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of TNFSF10 mRNA CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of TNFSF10 mRNA CTD PMID:30779732 amphibole asbestos decreases expression ISO RGD:1344832 6480464 Asbestos, Amphibole results in decreased expression of TNFSF10 protein CTD PMID:20855422 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1344832 6480464 pyrazolanthrone inhibits the reaction [sodium arsenite results in increased expression of TNFSF10 mRNA], pyrazolanthrone results in increased susceptibility to [[TNFSF10 protein co-treated with kahweol acetate] results in increased cleavage of PARP1 protein] CTD PMID:17545621 , PMID:20403343 antimony(0) decreases expression ISO RGD:1344832 6480464 Antimony results in decreased expression of TNFSF10 mRNA CTD PMID:17547211 antirheumatic drug decreases expression ISO RGD:1344832 6480464 Antirheumatic Agents results in decreased expression of TNFSF10 mRNA CTD PMID:17696278 apigenin multiple interactions ISO RGD:1344832 6480464 [TNFSF10 protein results in increased susceptibility to Apigenin] which results in decreased expression of BCL2 protein more ... CTD PMID:29247770 apigenin increases response to substance ISO RGD:1344832 6480464 TNFSF10 protein results in increased susceptibility to Apigenin CTD PMID:29247770 aripiprazole multiple interactions ISO RGD:1344832 6480464 [Aripiprazole co-treated with Ozone] results in decreased expression of TNFSF10 mRNA CTD PMID:31476115 aristolochic acid A decreases expression ISO RGD:1344832 6480464 aristolochic acid I results in decreased expression of TNFSF10 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:1344832 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of TNFSF10 mRNA CTD PMID:16934159 , PMID:17851650 arsane decreases expression ISO RGD:1344832 6480464 Arsenic results in decreased expression of TNFSF10 mRNA CTD PMID:19962721 arsane affects methylation ISO RGD:1344832 6480464 Arsenic affects the methylation of TNFSF10 gene CTD PMID:25304211 arsane increases methylation ISO RGD:1344832 6480464 Arsenic results in increased methylation of TNFSF10 gene CTD PMID:24525453 arsane increases expression ISO RGD:1344832 6480464 Arsenic results in increased expression of TNFSF10 mRNA CTD PMID:11134558 arsane multiple interactions ISO RGD:1344832 6480464 [Arsenic co-treated with Fluorides] results in decreased expression of TNFSF10 mRNA, [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of TNFSF10 mRNA CTD PMID:19962721 , PMID:32525701 arsenic atom decreases expression ISO RGD:1344832 6480464 Arsenic results in decreased expression of TNFSF10 mRNA CTD PMID:19962721 arsenic atom affects methylation ISO RGD:1344832 6480464 Arsenic affects the methylation of TNFSF10 gene CTD PMID:25304211 arsenic atom increases methylation ISO RGD:1344832 6480464 Arsenic results in increased methylation of TNFSF10 gene CTD PMID:24525453 arsenic atom increases expression ISO RGD:1344832 6480464 Arsenic results in increased expression of TNFSF10 mRNA CTD PMID:11134558 arsenic atom multiple interactions ISO RGD:1344832 6480464 [Arsenic co-treated with Fluorides] results in decreased expression of TNFSF10 mRNA, [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of TNFSF10 mRNA CTD PMID:19962721 , PMID:32525701 arsenite(3-) multiple interactions ISO RGD:1344832 6480464 arsenite promotes the reaction [G3BP1 protein binds to TNFSF10 mRNA] CTD PMID:32406909 arsenous acid decreases expression ISO RGD:1344832 6480464 Arsenic Trioxide results in decreased expression of TNFSF10 mRNA CTD PMID:17530438 more ... arsenous acid multiple interactions ISO RGD:1344832 6480464 [Arsenic Trioxide co-treated with Bortezomib] results in increased expression of TNFSF10 mRNA more ... CTD PMID:12851490 more ... arsenous acid increases expression ISO RGD:1344832 6480464 Arsenic Trioxide results in increased expression of TNFSF10 mRNA, Arsenic Trioxide results in increased expression of TNFSF10 protein CTD PMID:12851490 more ... arsenous acid increases response to substance ISO RGD:1344832 6480464 TNFSF10 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:24345465 atazanavir sulfate multiple interactions ISO RGD:1344832 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of TNFSF10 mRNA CTD PMID:33819548 atorvastatin calcium increases response to substance ISO RGD:1344832 6480464 TNFSF10 protein results in increased susceptibility to Atorvastatin CTD PMID:21910007 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of TNFSF10 gene CTD PMID:28931070 Auriculasin multiple interactions ISO RGD:1344832 6480464 [auriculasin co-treated with TNFSF10 protein] affects the expression of CASP10 protein more ... CTD PMID:30817944 beauvericin decreases expression ISO RGD:1344832 6480464 beauvericin results in decreased expression of TNFSF10 mRNA CTD PMID:29203277 benzo[a]pyrene decreases expression ISO RGD:732827 6480464 Benzo(a)pyrene results in decreased expression of TNFSF10 mRNA CTD PMID:21569818 benzo[a]pyrene decreases methylation ISO RGD:1344832 6480464 Benzo(a)pyrene results in decreased methylation of TNFSF10 exon CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:732827 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TNFSF10 mRNA CTD PMID:27858113 benzo[a]pyrene increases activity ISO RGD:1344832 6480464 Benzo(a)pyrene results in increased activity of TNFSF10 protein CTD PMID:22951985 benzo[a]pyrene increases expression ISO RGD:732827 6480464 Benzo(a)pyrene results in increased expression of TNFSF10 mRNA CTD PMID:22610609 benzo[a]pyrene multiple interactions ISO RGD:1344832 6480464 [Benzo(a)pyrene co-treated with TNFSF10 protein] results in increased cleavage of CASP8 protein more ... CTD PMID:22951985 benzo[b]fluoranthene multiple interactions ISO RGD:732827 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TNFSF10 mRNA CTD PMID:27858113 bepridil increases response to substance ISO RGD:1344832 6480464 Bepridil results in increased susceptibility to TNFSF10 protein CTD PMID:21292685 beta-carotene increases expression ISO RGD:1344832 6480464 beta Carotene results in increased expression of TNFSF10 mRNA CTD PMID:17034753 bis(2-chloroethyl) sulfide increases expression ISO RGD:732827 6480464 Mustard Gas results in increased expression of TNFSF10 mRNA CTD PMID:15674843 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of TNFSF10 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1344832 6480464 bisphenol A results in increased expression of TNFSF10 mRNA CTD PMID:29718440 bisphenol A affects expression ISO RGD:1344832 6480464 bisphenol A affects the expression of TNFSF10 mRNA CTD PMID:30903817 bisphenol A multiple interactions ISO RGD:1344832 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TNFSF10 mRNA CTD PMID:28628672 bisphenol F increases expression ISO RGD:1344832 6480464 bisphenol F results in increased expression of TNFSF10 mRNA CTD PMID:33476716 bortezomib multiple interactions ISO RGD:1344832 6480464 [Arsenic Trioxide co-treated with Bortezomib] results in increased expression of TNFSF10 mRNA more ... CTD PMID:12902978 more ... bortezomib multiple interactions ISO RGD:732827 6480464 BAK1 protein results in increased susceptibility to [Bortezomib co-treated with TNFSF10 protein] CTD PMID:12902978 bortezomib decreases expression ISO RGD:1344832 6480464 Bortezomib results in decreased expression of TNFSF10 mRNA, Bortezomib results in decreased expression of TNFSF10 protein CTD PMID:17172406 more ... brefeldin A multiple interactions ISO RGD:1344832 6480464 Brefeldin A affects the reaction [Bortezomib results in increased susceptibility to and results in increased activity of TNFSF10 protein] CTD PMID:17326159 bromoacetate decreases expression ISO RGD:1344832 6480464 bromoacetate results in decreased expression of TNFSF10 mRNA CTD PMID:19753638 buta-1,3-diene decreases expression ISO RGD:732827 6480464 1, 3-butadiene results in decreased expression of TNFSF10 mRNA CTD PMID:29038090 cadmium atom decreases expression ISO RGD:1344832 6480464 Cadmium results in decreased expression of TNFSF10 mRNA CTD PMID:17547211 , PMID:21120746 cadmium atom multiple interactions ISO RGD:1344832 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TNFSF10 mRNA CTD PMID:35301059 cadmium atom increases response to substance ISO RGD:732827 6480464 TNFSF10 results in increased susceptibility to Cadmium CTD PMID:12189181 cadmium dichloride decreases expression ISO RGD:1344832 6480464 Cadmium Chloride results in decreased expression of TNFSF10 mRNA CTD PMID:17547211 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of TNFSF10 mRNA CTD PMID:33453195 cadmium dichloride decreases expression ISO RGD:732827 6480464 Cadmium Chloride results in decreased expression of TNFSF10 mRNA CTD PMID:15501611 cadmium dichloride multiple interactions ISO RGD:1344832 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TNFSF10 mRNA, [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TNFSF10 mRNA CTD PMID:12634122 , PMID:35301059 Calcimycin multiple interactions ISO RGD:1344832 6480464 [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein more ... CTD PMID:21603612 cantharidin increases expression ISO RGD:1344832 6480464 Cantharidin results in increased expression of TNFSF10 protein CTD PMID:27113412 capsaicin multiple interactions ISO RGD:1344832 6480464 [Capsaicin co-treated with TNFSF10 protein] results in increased cleavage of CASP2 protein more ... CTD PMID:19939880 , PMID:22200406 capsaicin multiple interactions EXP 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TNFSF10 protein] more ... CTD PMID:22150557 capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of TNFSF10 protein CTD PMID:22150557 capsaicin increases response to substance ISO RGD:1344832 6480464 Capsaicin results in increased susceptibility to TNFSF10 protein CTD PMID:19939880 capsaicin increases expression ISO RGD:1344832 6480464 Capsaicin results in increased expression of TNFSF10 mRNA, Capsaicin results in increased expression of TNFSF10 protein CTD PMID:22200406 capsaicin increases activity ISO RGD:1344832 6480464 Capsaicin results in increased activity of TNFSF10 protein CTD PMID:22200406 carbon nanotube increases expression ISO RGD:1344832 6480464 Nanotubes, Carbon results in increased expression of TNFSF10 mRNA CTD PMID:23634900 carbon nanotube decreases expression ISO RGD:732827 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 carbon nanotube affects expression ISO RGD:732827 6480464 Nanotubes, Carbon affects the expression of TNFSF10 mRNA CTD PMID:23845593 carboxy-PTIO decreases response to substance ISO RGD:1344832 6480464 1 more ... CTD PMID:20971099 carboxy-PTIO multiple interactions ISO RGD:1344832 6480464 1 more ... CTD PMID:20971099 carmustine affects response to substance ISO RGD:1344832 6480464 TNFSF10 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 casticin increases expression ISO RGD:1344832 6480464 casticin results in increased expression of TNFSF10 protein CTD PMID:27862857 celastrol multiple interactions ISO RGD:1344832 6480464 [TNFSF10 protein co-treated with celastrol] results in increased cleavage of CASP3 protein more ... CTD PMID:20605676 celastrol increases expression ISO RGD:1344832 6480464 celastrol results in increased expression of TNFSF10 mRNA CTD PMID:25477506 celastrol increases response to substance ISO RGD:1344832 6480464 celastrol results in increased susceptibility to TNFSF10 protein CTD PMID:20605676 celecoxib multiple interactions ISO RGD:1344832 6480464 TNFSF10 protein promotes the reaction [Celecoxib results in increased cleavage of and results in increased activity of CASP3 protein] more ... CTD PMID:15572759 CGP 52608 multiple interactions ISO RGD:1344832 6480464 CGP 52608 promotes the reaction [RORA protein binds to TNFSF10 gene] CTD PMID:28238834 chenodeoxycholic acid multiple interactions ISO RGD:1344832 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of TNFSF10 mRNA more ... CTD PMID:33819548 chloroprene decreases expression ISO RGD:732827 6480464 Chloroprene results in decreased expression of TNFSF10 mRNA CTD PMID:23125180 chlorpyrifos increases expression ISO RGD:732827 6480464 Chlorpyrifos results in increased expression of TNFSF10 mRNA CTD PMID:22515965 , PMID:37019170 cholesterol increases expression EXP 6480464 Cholesterol analog results in increased expression of TNFSF10 mRNA, Cholesterol analog results in increased expression of TNFSF10 protein CTD PMID:19477266 chromium atom decreases expression ISO RGD:1344832 6480464 Chromium results in decreased expression of TNFSF10 mRNA CTD PMID:17547211 chromium(6+) affects expression ISO RGD:732827 6480464 chromium hexavalent ion affects the expression of TNFSF10 mRNA CTD PMID:28472532 chrysazin increases expression ISO RGD:1344832 6480464 danthron results in increased expression of TNFSF10 protein CTD PMID:21126053 chrysene multiple interactions ISO RGD:732827 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TNFSF10 mRNA CTD PMID:27858113 chrysin multiple interactions ISO RGD:1344832 6480464 chrysin promotes the reaction [TNFSF10 protein results in increased degradation of CASP3 protein], chrysin promotes the reaction [TNFSF10 protein results in increased degradation of CASP8 protein] CTD PMID:21195158 chrysin increases response to substance ISO RGD:1344832 6480464 chrysin results in increased susceptibility to TNFSF10 protein CTD PMID:21195158 cibenzoline increases response to substance ISO RGD:1344832 6480464 cifenline results in increased susceptibility to TNFSF10 protein CTD PMID:21292685 cisplatin multiple interactions ISO RGD:1344832 6480464 [Cisplatin co-treated with panobinostat] affects the expression of TNFSF10 mRNA more ... CTD PMID:20623264 more ... cisplatin multiple interactions EXP 6480464 tranilast inhibits the reaction [Cisplatin results in increased expression of TNFSF10 protein] CTD PMID:34047436 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of TNFSF10 protein CTD PMID:34047436 cisplatin increases response to substance ISO RGD:1344832 6480464 Cisplatin results in increased susceptibility to TNFSF10 protein CTD PMID:20856198 more ... cisplatin increases expression ISO RGD:1344832 6480464 Cisplatin results in increased expression of TNFSF10 mRNA, Cisplatin results in increased expression of TNFSF10 protein CTD PMID:20623264 more ... cisplatin affects response to substance ISO RGD:1344832 6480464 TNFSF10 protein affects the susceptibility to Cisplatin CTD PMID:16217747 , PMID:16638878 cisplatin increases uptake ISO RGD:1344832 6480464 Cisplatin results in increased uptake of TNFSF10 protein CTD PMID:21037225 cisplatin increases activity ISO RGD:1344832 6480464 Cisplatin results in increased activity of TNFSF10 protein CTD PMID:16638878 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of TNFSF10 mRNA CTD PMID:27899881 coformycin multiple interactions ISO RGD:732827 6480464 [Adenosine co-treated with Coformycin] results in decreased expression of TNFSF10 mRNA CTD PMID:11992407 copper atom increases expression EXP 6480464 Copper results in increased expression of TNFSF10 mRNA CTD PMID:30556269 copper atom multiple interactions ISO RGD:1344832 6480464 [Chelating Agents binds to Copper] which results in decreased expression of TNFSF10 mRNA CTD PMID:30911355 copper(0) increases expression EXP 6480464 Copper results in increased expression of TNFSF10 mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:1344832 6480464 [Chelating Agents binds to Copper] which results in decreased expression of TNFSF10 mRNA CTD PMID:30911355 copper(II) sulfate decreases expression ISO RGD:1344832 6480464 Copper Sulfate results in decreased expression of TNFSF10 mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO RGD:1344832 6480464 Asbestos, Crocidolite results in decreased expression of TNFSF10 mRNA CTD PMID:24160326 curcumin multiple interactions ISO RGD:1344832 6480464 Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of TNFSF10 mRNA] more ... CTD PMID:18226269 , PMID:23452621 curcumin decreases expression ISO RGD:1344832 6480464 Curcumin results in decreased expression of TNFSF10 mRNA CTD PMID:15713895 , PMID:16101141 cycloheximide multiple interactions ISO RGD:1344832 6480464 [Cycloheximide co-treated with TNFSF10 protein] results in increased activity of CASP3 protein more ... CTD PMID:11007951 more ... cyclosporin A increases expression ISO RGD:1344832 6480464 Cyclosporine results in increased expression of TNFSF10 mRNA CTD PMID:22147139 cyclosporin A decreases expression ISO RGD:1344832 6480464 Cyclosporine results in decreased expression of TNFSF10 mRNA CTD PMID:20106945 more ... cyclosporin A decreases response to substance ISO RGD:1344832 6480464 Cyclosporine results in decreased susceptibility to TNFSF10 protein CTD PMID:23711929 cyclosporin A multiple interactions ISO RGD:1344832 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of TNFSF10 mRNA, Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein] CTD PMID:21603612 , PMID:33819548 cylindrospermopsin decreases expression ISO RGD:1344832 6480464 cylindrospermopsin results in decreased expression of TNFSF10 mRNA CTD PMID:23726867 cytarabine multiple interactions ISO RGD:1344832 6480464 [Cytarabine co-treated with TNFSF10 protein] results in increased activity of CASP3 protein more ... CTD PMID:12780785 , PMID:18549619 cytarabine increases expression ISO RGD:1344832 6480464 Cytarabine results in increased expression of TNFSF10 mRNA CTD PMID:19194470 D-glucose decreases expression ISO RGD:1344832 6480464 Glucose results in decreased expression of TNFSF10 mRNA CTD PMID:31655124 dacarbazine multiple interactions ISO RGD:1344832 6480464 TNFSF10 protein promotes the reaction [Dacarbazine results in increased cleavage of and results in increased activity of CASP3 protein], TNFSF10 protein promotes the reaction [Dacarbazine results in increased cleavage of and results in increased activity of CASP8 protein] CTD PMID:17410615 daunorubicin multiple interactions ISO RGD:1344832 6480464 [Daunorubicin co-treated with TNFSF10 protein] results in increased activity of CASP3 protein more ... CTD PMID:12780785 , PMID:17204177 deoxycholic acid multiple interactions ISO RGD:1344832 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of TNFSF10 mRNA more ... CTD PMID:33819548 desferrioxamine B multiple interactions ISO RGD:1344832 6480464 [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TNFSF10 mRNA more ... CTD PMID:35690295 dexamethasone multiple interactions ISO RGD:1344832 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TNFSF10 mRNA more ... CTD PMID:16144937 more ... diallyl disulfide multiple interactions ISO RGD:1344832 6480464 benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [diallyl disulfide promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]] more ... CTD PMID:30677442 diallyl trisulfide increases response to substance ISO RGD:1344832 6480464 diallyl trisulfide results in increased susceptibility to TNFSF10 protein CTD PMID:28571773 diallyl trisulfide multiple interactions ISO RGD:1344832 6480464 [diallyl trisulfide results in increased susceptibility to TNFSF10 protein] which results in increased cleavage of CASP3 protein more ... CTD PMID:28571773 diarsenic trioxide increases expression ISO RGD:1344832 6480464 Arsenic Trioxide results in increased expression of TNFSF10 mRNA, Arsenic Trioxide results in increased expression of TNFSF10 protein CTD PMID:12851490 more ... diarsenic trioxide increases response to substance ISO RGD:1344832 6480464 TNFSF10 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:24345465 diarsenic trioxide decreases expression ISO RGD:1344832 6480464 Arsenic Trioxide results in decreased expression of TNFSF10 mRNA CTD PMID:17530438 more ... diarsenic trioxide multiple interactions ISO RGD:1344832 6480464 [Arsenic Trioxide co-treated with Bortezomib] results in increased expression of TNFSF10 mRNA more ... CTD PMID:12851490 more ... dibenz[a,h]anthracene increases expression ISO RGD:732827 6480464 1 more ... CTD PMID:26377693 dichloroacetic acid increases expression ISO RGD:732827 6480464 Dichloroacetic Acid results in increased expression of TNFSF10 mRNA CTD PMID:28962523 dichromium trioxide multiple interactions ISO RGD:1344832 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TNFSF10 mRNA CTD PMID:12634122 dicrotophos decreases expression ISO RGD:1344832 6480464 dicrotophos results in decreased expression of TNFSF10 mRNA CTD PMID:28302478 diethylstilbestrol increases expression ISO RGD:732827 6480464 Diethylstilbestrol results in increased expression of TNFSF10 mRNA CTD PMID:15545218 dihydroxyacetone decreases expression ISO RGD:1344832 6480464 Dihydroxyacetone results in decreased expression of TNFSF10 mRNA CTD PMID:32506039 dioxygen multiple interactions ISO RGD:1344832 6480464 3 more ... CTD PMID:23452621 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of TNFSF10 mRNA CTD PMID:33729688 dioxygen multiple interactions ISO RGD:732827 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TNFSF10 mRNA CTD PMID:30529165 dioxygen increases expression ISO RGD:1344832 6480464 Oxygen deficiency results in increased expression of TNFSF10 mRNA CTD PMID:23452621 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate decreases expression ISO RGD:1344832 6480464 Antimony Potassium Tartrate results in decreased expression of TNFSF10 mRNA CTD PMID:17547211 disodium selenite decreases expression ISO RGD:1344832 6480464 Sodium Selenite results in decreased expression of TNFSF10 mRNA CTD PMID:16705456 diuron decreases expression ISO RGD:1344832 6480464 Diuron results in decreased expression of TNFSF10 mRNA CTD PMID:35967413 dopamine decreases expression EXP 6480464 Dopamine results in decreased expression of TNFSF10 mRNA CTD PMID:21983523 doxorubicin multiple interactions EXP 6480464 chloroquine diphosphate promotes the reaction [Doxorubicin inhibits the reaction [Thioacetamide results in decreased expression of TNFSF10 mRNA]] more ... CTD PMID:29133031 doxorubicin decreases expression ISO RGD:1344832 6480464 Doxorubicin results in decreased expression of TNFSF10 mRNA CTD PMID:29803840 doxorubicin decreases expression ISO RGD:732827 6480464 Doxorubicin results in decreased expression of TNFSF10 mRNA CTD PMID:25896364 doxorubicin increases secretion EXP 6480464 Doxorubicin results in increased secretion of TNFSF10 protein CTD PMID:15703961 doxorubicin multiple interactions ISO RGD:732827 6480464 [Doxorubicin results in increased activity of SMPD1 protein] promotes the reaction [TNFSF10 protein binds to TNFSF10 protein] CTD PMID:17520194 doxorubicin multiple interactions ISO RGD:1344832 6480464 TNFSF10 protein promotes the reaction [Doxorubicin results in increased activity of CASP3 protein] more ... CTD PMID:19106633 doxorubicin affects response to substance ISO RGD:1344832 6480464 TNFSF10 affects the susceptibility to Doxorubicin, TNFSF10 protein affects the susceptibility to Doxorubicin CTD PMID:17283156 , PMID:19106633 doxorubicin increases expression ISO RGD:1344832 6480464 Doxorubicin results in increased expression of TNFSF10 mRNA, Doxorubicin results in increased expression of TNFSF10 protein CTD PMID:19106633 elemental selenium decreases expression ISO RGD:1344832 6480464 Selenium results in decreased expression of TNFSF10 mRNA CTD PMID:19244175 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of TNFSF10 mRNA CTD PMID:29391264 enniatin decreases expression EXP 6480464 enniatins results in decreased expression of TNFSF10 mRNA CTD PMID:27163883 entinostat multiple interactions ISO RGD:732827 6480464 TNFSF10 protein promotes the reaction [entinostat results in decreased activity of RELA protein] more ... CTD PMID:21041383 epoxiconazole decreases expression ISO RGD:732827 6480464 epoxiconazole results in decreased expression of TNFSF10 mRNA CTD PMID:35436446 ethanol decreases expression ISO RGD:732827 6480464 Ethanol results in decreased expression of TNFSF10 protein CTD PMID:18166357 ethanol multiple interactions ISO RGD:1344832 6480464 [Ethanol co-treated with FOXO3 protein] results in increased expression of TNFSF10 mRNA more ... CTD PMID:26470730 ethyl methanesulfonate increases expression ISO RGD:1344832 6480464 Ethyl Methanesulfonate results in increased expression of TNFSF10 mRNA CTD PMID:23649840 ethylene glycol bis(2-aminoethyl)tetraacetic acid multiple interactions ISO RGD:1344832 6480464 Egtazic Acid inhibits the reaction [Capsaicin results in increased expression of TNFSF10 mRNA] CTD PMID:22200406 fenoldopam decreases expression EXP 6480464 Fenoldopam results in decreased expression of TNFSF10 mRNA CTD PMID:21983523 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of TNFSF10 mRNA CTD PMID:18035473 formaldehyde increases expression ISO RGD:1344832 6480464 Formaldehyde results in increased expression of TNFSF10 mRNA CTD PMID:23649840 fumonisin B1 increases expression ISO RGD:732827 6480464 fumonisin B1 results in increased expression of TNFSF10 mRNA CTD PMID:15590129 furan decreases expression ISO RGD:732827 6480464 furan results in decreased expression of TNFSF10 mRNA CTD PMID:24183702 furosemide affects expression EXP 6480464 Furosemide affects the expression of TNFSF10 mRNA CTD PMID:17497460 Fusarenone X increases expression ISO RGD:732827 6480464 fusarenon-X results in increased expression of TNFSF10 mRNA CTD PMID:24983900 gadolinium trichloride increases expression ISO RGD:732827 6480464 gadolinium chloride results in increased expression of TNFSF10 mRNA CTD PMID:15590129 gemcitabine multiple interactions ISO RGD:1344832 6480464 [TNFSF10 co-treated with Gemcitabine] affects the localization of BAX protein, [TNFSF10 co-treated with Gemcitabine] results in increased activity of CASP8 protein CTD PMID:17671697 genistein multiple interactions ISO RGD:1344832 6480464 [Genistein co-treated with TNFSF10 protein] results in decreased expression of BCL2 protein more ... CTD PMID:19497411 , PMID:23452621 genistein decreases expression ISO RGD:732827 6480464 Genistein results in decreased expression of TNFSF10 mRNA CTD PMID:16169203 genistein increases response to substance ISO RGD:1344832 6480464 Genistein results in increased susceptibility to TNFSF10 protein CTD PMID:19497411 gingerol increases response to substance ISO RGD:1344832 6480464 gingerol results in increased susceptibility to TNFSF10 protein CTD PMID:25034532 gingerol multiple interactions ISO RGD:1344832 6480464 [gingerol results in increased expression of TP53 protein] which results in increased susceptibility to TNFSF10 protein more ... CTD PMID:25034532 glucose decreases expression ISO RGD:1344832 6480464 Glucose results in decreased expression of TNFSF10 mRNA CTD PMID:31655124 Glutathione ethyl ester multiple interactions ISO RGD:1344832 6480464 S-ethyl glutathione inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]], S-ethyl glutathione inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]] CTD PMID:25619640 glycochenodeoxycholic acid multiple interactions ISO RGD:1344832 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of TNFSF10 mRNA more ... CTD PMID:33819548 glycocholic acid multiple interactions ISO RGD:1344832 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of TNFSF10 mRNA more ... CTD PMID:33819548 glycodeoxycholic acid multiple interactions ISO RGD:1344832 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of TNFSF10 mRNA more ... CTD PMID:33819548 glyphosate decreases expression ISO RGD:1344832 6480464 glyphosate results in decreased expression of TNFSF10 mRNA CTD PMID:31295307 glyphosate decreases expression ISO RGD:732827 6480464 glyphosate results in decreased expression of TNFSF10 mRNA CTD PMID:35897073 gold atom decreases expression ISO RGD:1344832 6480464 Gold analog results in decreased expression of TNFSF10 mRNA CTD PMID:36057382 gold(0) decreases expression ISO RGD:1344832 6480464 Gold analog results in decreased expression of TNFSF10 mRNA CTD PMID:36057382 Ilimaquinone multiple interactions ISO RGD:1344832 6480464 [ilimaquinone results in increased susceptibility to TNFSF10 protein] which results in increased cleavage of CASP3 protein more ... CTD PMID:24930757 indometacin multiple interactions ISO RGD:1344832 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TNFSF10 mRNA CTD PMID:28628672 irinotecan multiple interactions ISO RGD:1344832 6480464 CFLAR protein alternative form inhibits the reaction [Irinotecan results in increased activity of TNFSF10 protein] CTD PMID:16373718 irinotecan increases activity ISO RGD:1344832 6480464 Irinotecan results in increased activity of TNFSF10 protein CTD PMID:16373718 iron atom increases expression ISO RGD:1344832 6480464 Iron deficiency results in increased expression of TNFSF10 mRNA CTD PMID:20368581 iron(0) increases expression ISO RGD:1344832 6480464 Iron deficiency results in increased expression of TNFSF10 mRNA CTD PMID:20368581 isoflurane decreases expression EXP 6480464 Isoflurane results in decreased expression of TNFSF10 mRNA CTD PMID:16978161 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of TNFSF10 mRNA CTD PMID:24286936 isotretinoin increases expression ISO RGD:1344832 6480464 Isotretinoin results in increased expression of TNFSF10 mRNA CTD PMID:18769122 ketoconazole multiple interactions ISO RGD:1344832 6480464 Ketoconazole inhibits the reaction [CYP26A1 protein inhibits the reaction [Tretinoin results in increased activity of TNFSF10 protein]] CTD PMID:15703382 kojic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TNFSF10 mRNA CTD PMID:18544905 L-ascorbic acid multiple interactions ISO RGD:1344832 6480464 [Quercetin co-treated with Ascorbic Acid] results in decreased expression of TNFSF10 mRNA more ... CTD PMID:17639512 , PMID:23711929 L-ascorbic acid decreases response to substance ISO RGD:1344832 6480464 Ascorbic Acid results in decreased susceptibility to TNFSF10 protein CTD PMID:23711929 Lasiocarpine decreases expression ISO RGD:1344832 6480464 lasiocarpine metabolite results in decreased expression of TNFSF10 mRNA CTD PMID:30465738 lead diacetate multiple interactions ISO RGD:1344832 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TNFSF10 mRNA CTD PMID:12634122 lead diacetate increases expression ISO RGD:732827 6480464 lead acetate results in increased expression of TNFSF10 mRNA CTD PMID:20542052 leflunomide decreases expression ISO RGD:1344832 6480464 leflunomide results in decreased expression of TNFSF10 mRNA CTD PMID:28988120 lipoic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in decreased expression of TNFSF10 mRNA CTD PMID:23830814 lipopolysaccharide multiple interactions ISO RGD:732827 6480464 3, 4-dihydroxybenzohydroxamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of TNFSF10 mRNA] CTD PMID:25843059 lipopolysaccharide multiple interactions ISO RGD:1344832 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of TNFSF10 mRNA] CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:1344832 6480464 Lipopolysaccharides results in increased expression of TNFSF10 mRNA CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:732827 6480464 Lipopolysaccharides results in increased expression of TNFSF10 mRNA CTD PMID:10975854 , PMID:25843059 lipopolysaccharide decreases expression ISO RGD:732827 6480464 Lipopolysaccharides results in decreased expression of TNFSF10 mRNA CTD PMID:23962744 lovastatin increases response to substance ISO RGD:1344832 6480464 Lovastatin results in increased susceptibility to TNFSF10 protein CTD PMID:17928957 luteolin multiple interactions ISO RGD:1344832 6480464 Luteolin promotes the reaction [TNFSF10 protein results in increased activity of CASP3 protein] more ... CTD PMID:16140950 LY294002 multiple interactions ISO RGD:1344832 6480464 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with TNFSF10 protein] results in increased activity of BAX protein more ... CTD PMID:19261616 more ... LY294002 increases expression ISO RGD:1344832 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of TNFSF10 protein CTD PMID:21179458 Maduramicin increases expression EXP 6480464 maduramicin results in increased expression of TNFSF10 protein CTD PMID:29047155 masoprocol multiple interactions ISO RGD:1344832 6480464 [Masoprocol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of BID protein more ... CTD PMID:17645780 mercury atom decreases expression ISO RGD:1344832 6480464 Mercury results in decreased expression of TNFSF10 mRNA CTD PMID:17547211 mercury(0) decreases expression ISO RGD:1344832 6480464 Mercury results in decreased expression of TNFSF10 mRNA CTD PMID:17547211 methotrexate increases expression ISO RGD:1344832 6480464 Methotrexate results in increased expression of TNFSF10 mRNA CTD PMID:17696278 , PMID:21678067 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of TNFSF10 gene CTD PMID:35440735 methyl methanesulfonate decreases expression ISO RGD:1344832 6480464 Methyl Methanesulfonate results in decreased expression of TNFSF10 mRNA CTD PMID:23649840 methyltestosterone multiple interactions ISO RGD:1344832 6480464 [Methyltestosterone co-treated with Cholic Acids] affects the expression of TNFSF10 mRNA CTD PMID:27344345 mevalonic acid multiple interactions ISO RGD:1344832 6480464 Mevalonic Acid inhibits the reaction [Simvastatin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]], Mevalonic Acid inhibits the reaction [TNFSF10 protein promotes the reaction [Simvastatin results in increased cleavage of PARP1 protein]] CTD PMID:21910007 mifepristone multiple interactions ISO RGD:1344832 6480464 Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [TNFSF10 protein results in increased activity of CASP3 protein]], Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [TNFSF10 protein results in increased activity of CASP8 protein]] CTD PMID:17070682 mithramycin multiple interactions ISO RGD:1344832 6480464 [Plicamycin inhibits the reaction [SP1 protein binds to TNFSF10 promoter]] which results in increased expression of TNFSF10 protein, Plicamycin inhibits the reaction [SP1 protein binds to TNFSF10 promoter] CTD PMID:21603612 mitomycin C multiple interactions ISO RGD:1344832 6480464 [Mitomycin co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein CTD PMID:15120327 monocrotaline multiple interactions ISO RGD:732827 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of TNFSF10 mRNA CTD PMID:21224054 morphine increases expression ISO RGD:732827 6480464 Morphine results in increased expression of TNFSF10 mRNA CTD PMID:16210602 Myrtucommulone A decreases expression ISO RGD:732827 6480464 myrtucommulone A results in decreased expression of TNFSF10 mRNA CTD PMID:26032814 N,N-dimethylformamide increases expression ISO RGD:1344832 6480464 Dimethylformamide results in increased expression of TNFSF10 mRNA, Dimethylformamide results in increased expression of TNFSF10 protein CTD PMID:18063697 N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide multiple interactions ISO RGD:1344832 6480464 N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide promotes the reaction [TNFSF10 protein results in increased expression of BIRC2 protein], N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide promotes the reaction [TNFSF10 protein results in increased expression of XIAP protein] CTD PMID:15520213 N-acetyl-L-cysteine decreases expression ISO RGD:1344832 6480464 Acetylcysteine results in decreased expression of TNFSF10 mRNA CTD PMID:16084531 N-acetyl-L-cysteine decreases response to substance ISO RGD:1344832 6480464 Acetylcysteine results in decreased susceptibility to TNFSF10 protein CTD PMID:20971099 , PMID:23711929 N-acetyl-L-cysteine multiple interactions ISO RGD:1344832 6480464 Acetylcysteine inhibits the reaction [[CSC-3436 co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein] more ... CTD PMID:20971099 more ... N-nitrosodiethylamine multiple interactions ISO RGD:732827 6480464 [dicyclanil co-treated with Diethylnitrosamine] results in decreased expression of TNFSF10 mRNA CTD PMID:17162532 N-nitrosodiethylamine multiple interactions EXP 6480464 3 more ... CTD PMID:18544905 more ... N-nitrosodimethylamine decreases expression ISO RGD:1344832 6480464 Dimethylnitrosamine results in decreased expression of TNFSF10 protein CTD PMID:17849272 naproxen multiple interactions EXP 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TNFSF10 protein], Naproxen inhibits the reaction [Capsaicin results in increased expression of TNFSF10 protein] CTD PMID:22150557 nefazodone multiple interactions ISO RGD:1344832 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of TNFSF10 mRNA CTD PMID:33819548 nickel atom decreases expression ISO RGD:1344832 6480464 Nickel results in decreased expression of TNFSF10 mRNA CTD PMID:23195993 nickel dichloride decreases expression ISO RGD:1344832 6480464 nickel chloride results in decreased expression of TNFSF10 mRNA CTD PMID:17547211 nickel dichloride increases expression ISO RGD:1344832 6480464 nickel chloride results in increased expression of TNFSF10 mRNA CTD PMID:17312168 nickel sulfate decreases expression ISO RGD:1344832 6480464 nickel sulfate results in decreased expression of TNFSF10 mRNA CTD PMID:18651567 NS-398 multiple interactions ISO RGD:1344832 6480464 [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [sodium arsenite results in increased expression of and results in increased localization of TNFRSF10B protein]] results in increased susceptibility to [TNFSF10 protein co-treated with Cycloheximide], [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [sodium arsenite results in increased expression of and results in increased localization of TNFRSF10B protein]] results in increased susceptibility to [TNFSF10 protein co-treated with resveratrol] CTD PMID:18222423 okadaic acid multiple interactions ISO RGD:1344832 6480464 Okadaic Acid inhibits the reaction [Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]] CTD PMID:16059913 olaparib multiple interactions ISO RGD:1344832 6480464 [olaparib co-treated with TNFSF10 protein] results in increased cleavage of CASP3 protein more ... CTD PMID:25531448 orlistat increases response to substance ISO RGD:1344832 6480464 orlistat results in increased susceptibility to TNFSF10 protein CTD PMID:18796435 , PMID:21406729 oxaliplatin multiple interactions ISO RGD:1344832 6480464 CFLAR protein alternative form inhibits the reaction [oxaliplatin results in increased activity of TNFSF10 protein] CTD PMID:16373718 oxaliplatin increases activity ISO RGD:1344832 6480464 oxaliplatin results in increased activity of TNFSF10 protein CTD PMID:16373718 ozone decreases expression ISO RGD:732827 6480464 Ozone results in decreased expression of TNFSF10 mRNA CTD PMID:17095637 ozone multiple interactions ISO RGD:732827 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of TNFSF10 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of TNFSF10 mRNA CTD PMID:34911549 ozone multiple interactions ISO RGD:1344832 6480464 [Aripiprazole co-treated with Ozone] results in decreased expression of TNFSF10 mRNA CTD PMID:31476115 ozone decreases expression ISO RGD:1344832 6480464 Ozone results in decreased expression of TNFSF10 mRNA CTD PMID:31476115 p-menthan-3-ol decreases expression ISO RGD:1344832 6480464 Menthol results in decreased expression of TNFSF10 mRNA CTD PMID:26760959 paclitaxel increases expression ISO RGD:1344832 6480464 Paclitaxel results in increased expression of TNFSF10 protein CTD PMID:15907983 Panduratin A increases expression ISO RGD:1344832 6480464 panduratin A results in increased expression of TNFSF10 protein CTD PMID:16497706 panobinostat multiple interactions ISO RGD:1344832 6480464 [Cisplatin co-treated with panobinostat] affects the expression of TNFSF10 mRNA CTD PMID:21791302 paracetamol decreases expression ISO RGD:1344832 6480464 Acetaminophen results in decreased expression of TNFSF10 mRNA CTD PMID:21420995 , PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of TNFSF10 mRNA CTD PMID:33387578 paracetamol multiple interactions ISO RGD:1344832 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of TNFSF10 mRNA CTD PMID:33819548 paraquat increases expression ISO RGD:732827 6480464 Paraquat results in increased expression of TNFSF10 mRNA CTD PMID:22938100 pentachlorophenol increases expression ISO RGD:732827 6480464 Pentachlorophenol results in increased expression of TNFSF10 mRNA CTD PMID:23892564 Pentoxifylline increases expression ISO RGD:1344832 6480464 Pentoxifylline results in increased expression of TNFSF10 mRNA CTD PMID:18851957 Pentoxifylline multiple interactions ISO RGD:1344832 6480464 [Pentoxifylline co-treated with TNFSF10 protein] results in decreased expression of BCL2L1 protein more ... CTD PMID:20804743 perfluorononanoic acid decreases expression ISO RGD:1344832 6480464 perfluoro-n-nonanoic acid results in decreased expression of TNFSF10 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1344832 6480464 perfluorooctane sulfonic acid results in decreased expression of TNFSF10 mRNA CTD PMID:27153767 , PMID:32588087 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1344832 6480464 perfluorooctane sulfonic acid results in increased expression of TNFSF10 mRNA CTD PMID:33772556 perfluorooctanoic acid decreases expression ISO RGD:1344832 6480464 perfluorooctanoic acid results in decreased expression of TNFSF10 mRNA CTD PMID:27153767 , PMID:32588087 perfluorooctanoic acid increases expression ISO RGD:1344832 6480464 perfluorooctanoic acid results in increased expression of TNFSF10 mRNA CTD PMID:33772556 phenobarbital increases expression ISO RGD:732827 6480464 Phenobarbital results in increased expression of TNFSF10 mRNA CTD PMID:19270015 phenobarbital multiple interactions EXP 6480464 3 more ... CTD PMID:27048571 phenobarbital affects expression ISO RGD:1344832 6480464 Phenobarbital affects the expression of TNFSF10 mRNA CTD PMID:19159669 phenytoin multiple interactions ISO RGD:732827 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of TNFSF10 mRNA CTD PMID:21224054 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1344832 6480464 [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein more ... CTD PMID:21603612 poly(I:C) increases expression ISO RGD:732827 6480464 Poly I-C results in increased expression of TNFSF10 mRNA, Poly I-C results in increased expression of TNFSF10 protein CTD PMID:16472598 potassium chromate decreases expression ISO RGD:1344832 6480464 potassium chromate(VI) results in decreased expression of TNFSF10 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1344832 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TNFSF10 mRNA CTD PMID:22079256 potassium dichromate decreases expression ISO RGD:1344832 6480464 Potassium Dichromate results in decreased expression of TNFSF10 mRNA CTD PMID:17547211 progesterone decreases expression ISO RGD:1344832 6480464 Progesterone results in decreased expression of TNFSF10 mRNA CTD PMID:18070364 progesterone multiple interactions ISO RGD:1344832 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of TNFSF10 mRNA CTD PMID:20660070 propylparaben increases expression ISO RGD:1344832 6480464 propylparaben results in increased expression of TNFSF10 mRNA CTD PMID:24481588 Protolichesterinic acid increases expression ISO RGD:1344832 6480464 protolichesterinic acid results in increased expression of TNFSF10 protein CTD PMID:22063921 pyrethrins decreases expression ISO RGD:1344832 6480464 Pyrethrins results in decreased expression of TNFSF10 mRNA CTD PMID:35321623 quartz decreases expression ISO RGD:1344832 6480464 Quartz results in decreased expression of TNFSF10 mRNA CTD PMID:27917503 quercetin decreases expression ISO RGD:1344832 6480464 Quercetin results in decreased expression of TNFSF10 mRNA CTD PMID:21632981 quercetin increases expression ISO RGD:1344832 6480464 Quercetin results in increased expression of TNFSF10 protein CTD PMID:30152185 quercetin multiple interactions ISO RGD:1344832 6480464 [Quercetin co-treated with Ascorbic Acid] results in decreased expression of TNFSF10 mRNA more ... CTD PMID:17548900 more ... quercetin increases response to substance ISO RGD:1344832 6480464 Quercetin results in increased susceptibility to TNFSF10 protein CTD PMID:20096292 more ... quinolin-8-ol increases expression ISO RGD:1344832 6480464 Oxyquinoline results in increased expression of TNFSF10 mRNA CTD PMID:21632981 rac-lactic acid decreases expression ISO RGD:1344832 6480464 Lactic Acid results in decreased expression of TNFSF10 mRNA CTD PMID:30851411 reactive nitrogen species multiple interactions ISO RGD:1344832 6480464 1 more ... CTD PMID:20971099 reactive nitrogen species increases abundance ISO RGD:1344832 6480464 TNFSF10 protein results in increased abundance of Reactive Nitrogen Species CTD PMID:20971099 reactive oxygen species multiple interactions ISO RGD:1344832 6480464 6-hydroxy-2 more ... CTD PMID:20971099 , PMID:23711929 reactive oxygen species increases chemical synthesis ISO RGD:1344832 6480464 TNFSF10 protein results in increased chemical synthesis of Reactive Oxygen Species CTD PMID:23711929 reactive oxygen species increases abundance ISO RGD:1344832 6480464 TNFSF10 protein results in increased abundance of Reactive Oxygen Species CTD PMID:20971099 rebaudioside A decreases expression ISO RGD:1344832 6480464 rebaudioside A results in decreased expression of TNFSF10 mRNA CTD PMID:31655124 reserpine multiple interactions EXP 6480464 IAPP protein inhibits the reaction [Reserpine results in increased expression of TNFSF10 protein] CTD PMID:19463876 reserpine increases expression EXP 6480464 Reserpine results in increased expression of TNFSF10 protein CTD PMID:19463876 resveratrol multiple interactions ISO RGD:1344832 6480464 [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [sodium arsenite results in increased expression of and results in increased localization of TNFRSF10B protein]] results in increased susceptibility to [TNFSF10 protein co-treated with resveratrol] more ... CTD PMID:15763656 more ... resveratrol increases expression ISO RGD:1344832 6480464 resveratrol results in increased expression of TNFSF10 protein CTD PMID:21179458 resveratrol increases response to substance ISO RGD:1344832 6480464 resveratrol results in increased susceptibility to TNFSF10 protein, TNFSF10 protein results in increased susceptibility to resveratrol CTD PMID:18222423 , PMID:20097879 ribavirin decreases response to substance ISO RGD:1344832 6480464 Ribavirin results in decreased susceptibility to TNFSF10 protein CTD PMID:12637521 riddelliine increases expression EXP 6480464 riddelliine results in increased expression of TNFSF10 mRNA CTD PMID:18047727 rifampicin multiple interactions ISO RGD:732827 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of TNFSF10 mRNA CTD PMID:21224054 Ro 31-8220 multiple interactions ISO RGD:1344832 6480464 Ro 31-8220 inhibits the reaction [decitabine results in increased expression of TNFSF10 protein] CTD PMID:17283156 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of TNFSF10 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1344832 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of TNFSF10 mRNA] CTD PMID:35811015 sanguinarine increases expression ISO RGD:1344832 6480464 sanguinarine results in increased expression of TNFSF10 mRNA CTD PMID:24345465 sanguinarine multiple interactions ISO RGD:1344832 6480464 [sanguinarine co-treated with arsenic trioxide co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein more ... CTD PMID:24345465 SB 203580 increases response to substance ISO RGD:1344832 6480464 SB 203580 results in increased susceptibility to TNFSF10 protein CTD PMID:19497411 SB 203580 multiple interactions ISO RGD:1344832 6480464 SB 203580 inhibits the reaction [CSC-3436 promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]], SB 203580 inhibits the reaction [TNFSF10 protein promotes the reaction [CSC-3436 results in increased cleavage of PARP1 protein]] CTD PMID:34599545 Se-methyl-L-selenocysteine multiple interactions ISO RGD:1344832 6480464 [selenomethylselenocysteine results in decreased expression of BCL2 mRNA] which results in increased activity of TNFSF10 protein CTD PMID:19360359 Se-methylselenocysteine multiple interactions ISO RGD:1344832 6480464 [selenomethylselenocysteine results in decreased expression of BCL2 mRNA] which results in increased activity of TNFSF10 protein CTD PMID:19360359 selenium atom decreases expression ISO RGD:1344832 6480464 Selenium results in decreased expression of TNFSF10 mRNA CTD PMID:19244175 serpentine asbestos increases expression ISO RGD:1344832 6480464 Asbestos, Serpentine results in increased expression of TNFSF10 mRNA CTD PMID:24160326 silicon dioxide decreases expression ISO RGD:1344832 6480464 Silicon Dioxide analog results in decreased expression of TNFSF10 mRNA, Silicon Dioxide results in decreased expression of TNFSF10 mRNA CTD PMID:25895662 , PMID:27917503 silver atom decreases expression ISO RGD:1344832 6480464 Silver analog results in decreased expression of TNFSF10 mRNA CTD PMID:24462830 silver(0) decreases expression ISO RGD:1344832 6480464 Silver analog results in decreased expression of TNFSF10 mRNA CTD PMID:24462830 simvastatin increases response to substance ISO RGD:1344832 6480464 TNFSF10 protein results in increased susceptibility to Simvastatin CTD PMID:21910007 simvastatin multiple interactions ISO RGD:1344832 6480464 [Simvastatin co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein more ... CTD PMID:21910007 SM-164 increases response to substance ISO RGD:1344832 6480464 TNFSF10 protein results in increased susceptibility to SM 164 CTD PMID:22241084 sodium arsenate multiple interactions ISO RGD:1344832 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of TNFSF10 mRNA CTD PMID:32525701 sodium arsenite multiple interactions ISO RGD:1344832 6480464 [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [sodium arsenite results in increased expression of and results in increased localization of TNFRSF10B protein]] results in increased susceptibility to [TNFSF10 protein co-treated with Cycloheximide] more ... CTD PMID:12634122 more ... sodium arsenite decreases expression ISO RGD:732827 6480464 sodium arsenite results in decreased expression of TNFSF10 mRNA CTD PMID:19822182 , PMID:36209798 sodium arsenite increases expression ISO RGD:1344832 6480464 sodium arsenite results in increased expression of TNFSF10 mRNA, sodium arsenite results in increased expression of TNFSF10 protein CTD PMID:15028728 more ... sodium arsenite decreases expression ISO RGD:1344832 6480464 sodium arsenite results in decreased expression of TNFSF10 mRNA CTD PMID:12727804 sodium arsenite affects localization ISO RGD:1344832 6480464 sodium arsenite affects the localization of TNFSF10 protein CTD PMID:17545621 sodium dodecyl sulfate decreases expression ISO RGD:1344832 6480464 Sodium Dodecyl Sulfate results in decreased expression of TNFSF10 mRNA CTD PMID:31734321 sorafenib multiple interactions ISO RGD:1344832 6480464 [[Sorafenib results in increased expression of DDIT4 protein] which results in decreased activity of MTOR protein] which results in increased susceptibility to TNFSF10 protein more ... CTD PMID:17909059 more ... sorafenib increases response to substance ISO RGD:1344832 6480464 sorafenib results in increased susceptibility to TNFSF10 protein CTD PMID:20071162 steviol decreases expression ISO RGD:1344832 6480464 steviol results in decreased expression of TNFSF10 mRNA CTD PMID:31655124 stevioside decreases expression ISO RGD:1344832 6480464 stevioside results in decreased expression of TNFSF10 mRNA CTD PMID:31655124 styrene increases expression ISO RGD:1344832 6480464 Styrene results in increased expression of TNFSF10 mRNA CTD PMID:24086524 styrene multiple interactions ISO RGD:1344832 6480464 Styrene results in increased expression of and results in increased secretion of TNFSF10 protein CTD PMID:24086524 succimer multiple interactions ISO RGD:1344832 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNFSF10 mRNA CTD PMID:26378955 sulforaphane increases activity ISO RGD:1344832 6480464 sulforaphane results in increased activity of TNFSF10 protein CTD PMID:29792947 sulforaphane multiple interactions ISO RGD:1344832 6480464 [sulforaphane co-treated with TNFSF10 protein] results in decreased expression of CASP3 protein more ... CTD PMID:29792947 sulindac increases response to substance ISO RGD:1344832 6480464 Sulindac results in increased susceptibility to TNFSF10 protein CTD PMID:21171083 sulindac multiple interactions ISO RGD:1344832 6480464 [Sulindac co-treated with TNFSF10 protein] results in increased activity of CASP8 protein, TCF4 protein promotes the reaction [Sulindac results in increased susceptibility to TNFSF10 protein] CTD PMID:21171083 sulindac sulfide multiple interactions ISO RGD:1344832 6480464 BAX protein affects the reaction [TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP3 protein]] more ... CTD PMID:12203115 sumatriptan multiple interactions EXP 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TNFSF10 protein], Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TNFSF10 protein] CTD PMID:22150557 Sunset Yellow FCF multiple interactions ISO RGD:1344832 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of TNFSF10 mRNA CTD PMID:33819548 tamibarotene increases expression ISO RGD:1344832 6480464 tamibarotene results in increased expression of TNFSF10 mRNA CTD PMID:15498508 tamibarotene increases activity ISO RGD:1344832 6480464 tamibarotene results in increased activity of TNFSF10 protein CTD PMID:15703382 tamoxifen multiple interactions ISO RGD:1344832 6480464 [Tamoxifen co-treated with TNFSF10 protein] results in decreased expression of BCL2 protein more ... CTD PMID:17767197 tanespimycin multiple interactions ISO RGD:1344832 6480464 [tanespimycin co-treated with TNFSF10 protein] results in decreased expression of XIAP protein, [tanespimycin co-treated with TNFSF10 protein] results in increased activity of CASP3 protein CTD PMID:15993848 Tanshinone I increases response to substance ISO RGD:1344832 6480464 tanshinone results in increased susceptibility to TNFSF10 protein CTD PMID:26203587 Tanshinone I multiple interactions ISO RGD:1344832 6480464 [TNFSF10 protein co-treated with tanshinone] results in increased cleavage of PARP1 protein more ... CTD PMID:26203587 tartrazine multiple interactions ISO RGD:1344832 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of TNFSF10 mRNA CTD PMID:33819548 temozolomide affects response to substance ISO RGD:1344832 6480464 TNFSF10 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 temozolomide increases expression ISO RGD:1344832 6480464 Temozolomide results in increased expression of TNFSF10 mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases expression ISO RGD:1344832 6480464 tert-Butylhydroperoxide results in decreased expression of TNFSF10 mRNA CTD PMID:15336504 tert-butyl hydroperoxide multiple interactions ISO RGD:1344832 6480464 [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TNFSF10 mRNA more ... CTD PMID:35690295 testosterone decreases expression ISO RGD:732827 6480464 Testosterone results in decreased expression of TNFSF10 mRNA CTD PMID:19693291 testosterone increases expression ISO RGD:732827 6480464 Testosterone results in increased expression of TNFSF10 mRNA CTD PMID:19693291 testosterone enanthate affects expression ISO RGD:1344832 6480464 testosterone enanthate affects the expression of TNFSF10 mRNA CTD PMID:17440010 tetrachloromethane increases expression ISO RGD:732827 6480464 Carbon Tetrachloride results in increased expression of TNFSF10 mRNA, Carbon Tetrachloride results in increased expression of TNFSF10 protein CTD PMID:17038628 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TNFSF10 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of TNFSF10 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions ISO RGD:732827 6480464 Glatiramer Acetate promotes the reaction [Carbon Tetrachloride results in increased expression of TNFSF10 mRNA], Glatiramer Acetate promotes the reaction [Carbon Tetrachloride results in increased expression of TNFSF10 protein] CTD PMID:17038628 tetraphene multiple interactions ISO RGD:732827 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TNFSF10 mRNA CTD PMID:27858113 thalidomide decreases expression ISO RGD:1344832 6480464 Thalidomide results in decreased expression of TNFSF10 protein CTD PMID:16531263 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in decreased expression of TNFSF10 mRNA more ... CTD PMID:23830814 , PMID:29133031 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of TNFSF10 mRNA CTD PMID:23411599 more ... thiophenes multiple interactions ISO RGD:1344832 6480464 Thiophenes analog promotes the reaction [Tretinoin results in increased expression of TNFSF10 mRNA] CTD PMID:16140955 titanium dioxide increases expression ISO RGD:732827 6480464 titanium dioxide results in increased expression of TNFSF10 mRNA CTD PMID:23557971 tofacitinib decreases expression ISO RGD:1344832 6480464 tofacitinib results in decreased expression of TNFSF10 mRNA CTD PMID:25487280 tranilast multiple interactions EXP 6480464 tranilast inhibits the reaction [Cisplatin results in increased expression of TNFSF10 protein] CTD PMID:34047436 Triptolide increases expression ISO RGD:732827 6480464 triptolide results in increased expression of TNFSF10 protein CTD PMID:26990902 troglitazone increases response to substance ISO RGD:1344832 6480464 troglitazone results in increased susceptibility to TNFSF10 protein CTD PMID:16820965 troglitazone decreases expression ISO RGD:1344832 6480464 troglitazone results in decreased expression of TNFSF10 mRNA CTD PMID:19631733 tungsten decreases expression ISO RGD:732827 6480464 Tungsten results in decreased expression of TNFSF10 mRNA CTD PMID:30912803 tunicamycin decreases expression ISO RGD:732827 6480464 Tunicamycin results in decreased expression of TNFSF10 mRNA CTD PMID:17127020 urethane decreases expression ISO RGD:1344832 6480464 Urethane results in decreased expression of TNFSF10 mRNA CTD PMID:28818685 valproic acid multiple interactions ISO RGD:1344832 6480464 [Valproic Acid co-treated with decitabine co-treated with TNFSF10 protein] results in increased activity of BAX protein more ... CTD PMID:21771726 valproic acid decreases expression ISO RGD:1344832 6480464 Valproic Acid results in decreased expression of TNFSF10 mRNA CTD PMID:29154799 venom increases response to substance ISO RGD:1344832 6480464 Viper Venoms results in increased susceptibility to TNFSF10 protein CTD PMID:25417048 venom multiple interactions ISO RGD:1344832 6480464 TNFSF10 protein promotes the reaction [Viper Venoms results in increased expression of TNFRSF10B protein] CTD PMID:25417048 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of TNFSF10 mRNA CTD PMID:23034163 vincristine increases expression ISO RGD:1344832 6480464 Vincristine results in increased expression of TNFSF10 mRNA CTD PMID:23649840 vitamin D affects expression ISO RGD:1344832 6480464 Vitamin D affects the expression of TNFSF10 mRNA CTD PMID:20368581 vitamin E decreases expression ISO RGD:1344832 6480464 Vitamin E results in decreased expression of TNFSF10 mRNA CTD PMID:19244175 vorinostat multiple interactions ISO RGD:1344832 6480464 [vorinostat co-treated with TNFSF10 protein] affects the localization of CASP8 protein more ... CTD PMID:16450389 more ... vorinostat increases response to substance ISO RGD:1344832 6480464 vorinostat results in increased susceptibility to TNFSF10 protein CTD PMID:19509267 more ... vorinostat increases expression ISO RGD:1344832 6480464 Vorinostat results in increased expression of TNFSF10 mRNA, Vorinostat results in increased expression of TNFSF10 protein CTD PMID:17410615 , PMID:18025281 Y-27632 decreases expression ISO RGD:1344832 6480464 Y 27632 results in decreased expression of TNFSF10 mRNA CTD PMID:20878077 zearalenone increases expression ISO RGD:1344832 6480464 Zearalenone results in increased expression of TNFSF10 mRNA CTD PMID:27757495 zidovudine multiple interactions ISO RGD:1344832 6480464 [Zidovudine co-treated with IFNA1 protein] results in increased expression of TNFSF10 mRNA CTD PMID:20370541
